The U.S. healthcare industry is in the middle of a structural transformation. Decades of underinvestment in technology, accelerated by pandemic-era digital adoption, have created unprecedented demand for healthcare technology solutions. For startups building in this space, the timing is exceptional — but only for those who move deliberately and with a credible commercial strategy.
Market Size and Growth Trajectory
The U.S. digital health market is projected to exceed $800 billion by 2030, growing at a CAGR of over 18%. Within that, healthcare IT — covering EHR, revenue cycle management, patient engagement, and clinical decision support — represents the largest and fastest-growing segment. The shift from fee-for-service to value-based care models is driving health systems to invest in technology that demonstrates measurable outcomes, creating direct purchasing motivation at the health system and payer level.
- U.S. digital health investment exceeded $29 billion in 2021 and remains elevated post-correction
- Value-based care adoption is now above 60% of commercial contracts, creating outcome-tech demand
- CMS reimbursement changes are pushing providers toward technology that supports documentation and compliance
- Pharmacy sector technology spend is growing at 12% annually as chains modernise operations
Mid-article CTA
Need help building your healthcare growth engine?
Medix helps healthcare startups, clinics, pharma companies, and provider-focused platforms build scalable commercial pipelines.
Book a Strategy CallDigital Health Adoption Trends
The COVID-19 pandemic permanently shifted provider attitudes toward digital health tools. Telehealth adoption among physicians went from under 5% to over 70% in a matter of months and has stabilised well above pre-pandemic levels. Beyond telehealth, electronic prior authorisation, remote patient monitoring, and AI-assisted clinical decision support have all achieved mainstream adoption thresholds. Providers who resisted digital tools before 2020 are now active buyers.
Pro tip
The buyers who were once your biggest obstacle — technology-resistant clinicians — are now actively seeking solutions. The market has done the early education work for you.
Why the Window of Opportunity Is Now
Market windows in healthcare don't stay open indefinitely. As the sector matures, larger incumbents (Epic, Cerner, Oracle Health) are expanding their platform footprints, acquiring best-of-breed point solutions, and making it harder for standalone startups to compete on breadth. The current window favours startups that can demonstrate depth in a specific clinical or operational niche, move fast to build reference accounts, and scale distribution before the consolidation wave hits their category.